Abstract:Abstract Aggregation of α-synuclein plays a key role in the development of Parkinson’s disease. Soluble aggregates are present not only within human brain but also the CSF and blood. Characterizing the aggregates present in these biofluids may provide insights into disease mechanisms and also have potential for aiding diagnosis. We used two optical single-molecule imaging methods called aptamer DNA-PAINT and single-aggregate confocal fluorescence, together with high-resolution atomic force microscopy for specific detection and characterization of individual aggregates with intermolecular β-sheet structure, present in the CSF and serum of 15 early stage Parkinson’s disease patients compared to 10 healthy age-matched controls. We found aggregates ranging in size from 20 nm to 200 nm, in both CSF and serum. There was a difference in aggregate size distribution between Parkinson’s disease and control groups with a significantly increased number of larger aggregates (longer than 150 nm) in the serum of patients with Parkinson’s disease. To determine the chemical composition of the aggregates, we performed aptamer DNA-PAINT on serum following α-synuclein and amyloid-β immunodepletion in an independent cohort of 11 patients with early stage Parkinson’s disease and 10 control subjects. β-Sheet aggregates in the serum of Parkinson’s disease patients were found to consist of, on average, 50% α-synuclein and 50% amyloid-β in contrast to 30% α-synuclein and 70% amyloid-β in control serum [the differences in the proportion of these aggregates were statistically significant between diseased and control groups (P = 1.7 × 10−5 for each species)]. The ratio of the number of β-sheet α-synuclein aggregates to β-sheet amyloid-β aggregates in serum extracted using our super-resolution method discriminated Parkinson’s disease cases from controls with an accuracy of 98.2% (AUC = 98.2%, P = 4.3 × 10−5). Our data suggest that studying the protein aggregates present in serum can provide information about the disruption of protein homeostasis occurring in Parkinson’s disease and warrants further investigation as a potential biomarker of disease.

Extrinsic Amyloid-Binding Dyes for Detection of Individual Protein Aggregates in Solution

Single‐molecule two‐color coincidence detection of unlabeled alpha‐synuclein aggregates

Cross-Reactive Fluorescent Sensor Array for Discrimination of Amyloid Beta Aggregates

A Novel Viscosity Sensitive Hemicyanine Fluorescent Dye for Real-Time Imaging of Amyloid-Β Aggregation

Fluorescence Self-Quenching from Reporter Dyes Informs on the Structural Properties of Amyloid Clusters Formed in Vitro and in Cells

Detection of Protein Aggregation in Neurodegenerative Diseases

Quantitative detection of α-Synuclein and Tau oligomers and other aggregates by digital single particle counting

Interrogating Amyloid Aggregation with Aggregation-Induced Emission Fluorescence Probes.

Fundamentals and exploration of aggregation-induced emission molecules for amyloid protein aggregation

Real-Time Monitoring of Self-Aggregation of Β-Amyloid by a Fluorescent Probe Based on Ruthenium Complex.

Real-Time 3D Imaging and Inhibition Analysis of Various Amyloid Aggregations Using Quantum Dots

Modulation of AIE and Intramolecular Charge Transfer of a Pyrene-Based Probe for Discriminatory Detection and Imaging of Oligomers and Amyloid Fibrils

Fluorescence Lifetime-Assisted Probing of Protein Aggregation with sub-Organellar Resolution

Chemical Fluorescent Probe for Detection of Aβ Oligomers

Imaging protein aggregates in the serum and cerebrospinal fluid in Parkinson’s disease

A mix-and-click method to measure amyloid-β concentration with sub-micromolar sensitivity

Heterogeneous and Surface-Catalyzed Amyloid Aggregation Monitored by Spatially Resolved Fluorescence and Single Molecule Microscopy

In Situ Monitoring the Aggregation Dynamics of Amyloid-β Protein Aβ42 in Physiological Media Via a Raman-Based Frequency Shift Method.

Mitochondria Targeted De Novo Designed Aggregation-Induced Emission Probe for Selective Detection of Neurotoxic Amyloid‐β Aggregates

Single‐Molecule Characterization and Super‐Resolution Imaging of Alzheimer's Disease‐Relevant Tau Aggregates in Human Samples

Machine Learning-Assisted Fluorescence/fluorescence Colorimetric Sensor Array for Discriminating Amyloid Fibrils